Carnegie Investment Counsel’s Alcentra Capital Corp ABDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-18,111
Closed -$184K 386
2017
Q3
$184K Sell
18,111
-1,900
-9% -$21.7K 0.02% 341
2017
Q2
$232K Buy
20,011
+1,500
+8% +$20.7K 0.03% 321
2017
Q1
$267K Hold
18,511
0.03% 297
2016
Q4
$233K Buy
18,511
+1,100
+6% +$13.6K 0.03% 302
2016
Q3
$222K Buy
+17,411
New +$218K 0.03% 294

Other funds holding ABDC

Carnegie Investment Counsel's ABDC Position: Q4 2017 in Review

Carnegie Investment Counsel sold out of Alcentra Capital Corp (ABDC) in Q4 2017, closing a stake of 18,111 shares — an estimated $184K sold.

Carnegie Investment Counsel first reported a position in ABDC in Q3 2016 and held it in 5 quarters. The position peaked at $267K in Q1 2017. 40 funds tracked by Wall St. Rank hold ABDC as of Q4 2017.

  • Carnegie Investment Counsel reported no remaining Alcentra Capital Corp position as of Q4 2017 after selling out during the quarter.
  • Carnegie Investment Counsel sold 18,111 Alcentra Capital Corp shares in Q4 2017, an estimated $184K.
  • Carnegie Investment Counsel first reported a position in Alcentra Capital Corp in Q3 2016 and held it in 5 quarters.
  • Carnegie Investment Counsel's Alcentra Capital Corp position peaked at $267K in Q1 2017.
  • 40 funds tracked by Wall St. Rank held Alcentra Capital Corp as of Q4 2017.

Based on Carnegie Investment Counsel's 13F filing for Q4 2017, filed 12 Feb 2018.